News
U.S. Lawmakers Eyeing Federal Cryptocurrency Rules
Jolted by the global investment craze over bitcoin and other cryptocurrencies, U.S. lawmakers are moving to consider new rules that could impose stricter federal oversight on the emerging asset ...
Researchers Sound Alarm on AI Hacking Risk, Malicious Use by Lone Wolves, Rogue States
Rapid advances in artificial intelligence are raising risks that malicious users will soon exploit the technology to mount automated hacking attacks, cause driverless car crashes or turn commercial ...
Hamilton Insurance Group Reorganizes Lloyd’s Underwriting Operations
Hamilton Insurance Group said it has reorganized a key underwriting team involving its Lloyd's operations after the departure of two executives. Hamilton Underwriting Ltd.—the managing agency of ...
Liberty Mutual’s Safeco to Take Over MAPFRE’s Personal Lines Biz in Three States
MAPFRE Insurance, which last year decided to exit five states and focus on 11, is turning over its personal lines business in three of those five states to Safeco Insurance, a Liberty Mutual unit. ...
UK’s Legal & General Seals Deal to Bring Slice Lab’s On-Demand Insurance Platform Overseas
Slice Labs, a New York-based developer of on-demand insurance, has expanded overseas for the first time through a new partnership with the venerable UK carrier Legal & General. Their initial ...
Finding Qualified Insurance Employees Remains a Challenge Even as Hiring Stabilizes
Fifty-eight percent of insurance companies plan to increase staff during the next 12 months, in part due to an expected increase in business and new markets, according to the Semi-Annual U.S. ...
Obscure N. Korea Cyber Espionage Group Reportedly Broadens Reach
A North Korean cyber espionage group previously known only for targeting South Korea's government and private sector deepened its sophistication and hit further afield including in Japan and the ...
Gilead Wins as Judge Reverses Record $2.54B Hepatitis C Drug Patent Verdict
A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc. to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by ...